The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
Somatostatin Analogue ID: ALA2448343
Max Phase: Preclinical
Molecular Formula: C67H94CuN14O18S2+2
Molecular Weight: 1511.25
Molecule Type: Unknown
Associated Items:
Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Properties Molecular Weight: 1511.25Molecular Weight (Monoisotopic): 1509.5597AlogP: #Rotatable Bonds: Polar Surface Area: Molecular Species: HBA: HBD: #RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski): CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD: Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:
References 1. Lewis JS, Lewis MR, Srinivasan A, Schmidt MA, Wang J, Anderson CJ.. (1999) Comparison of four 64Cu-labeled somatostatin analogues in vitro and in a tumor-bearing rat model: evaluation of new derivatives for positron emission tomography imaging and targeted radiotherapy., 42 (8): [PMID:10212119 ] [10.1021/jm980602h ]